Abstract:Abstract Background: Hepatitis B surface antigen (HBsAg) and viral load are important clinical indicators for patients with chronic hepatitis B (CHB) infection treated with antiviral therapy. Few studies have evaluated viral sequence biomarkers predicting the risk of hepatocellular carcinoma (HCC) in the stage, which show a low serological response (HBsAg <100 IU/ml) and high viral levels (HBV DNA >2,000 IU/ml). Additionally, point mutations within the pre S/S regions of HBsAg have frequently been reported to be associated with diagnostic failure, vaccine escape and immunotherapy escape. However, the prevalence of escape mutations with low levels of HBsAg (<100 IU/ml) in inactive HBsAg carriers has not been systematically studied within the past decade. Methods: This study aims to determine the trend of the biological prevalence of escape mutations within the pre S/S regions of special model of inactive CHB infection. Increased diversity over the complete HBV genome at baseline was associated with evolutionary characteristics. We used Sanger sequencing, quantitative HBV serology (HBeAg and HBsAg) and liver function index (aspartate alanine aminotransferase, ALT; alanine aminotransferase, AST) to identify whether HBV genome sequences are associated with the serological response to long-term host immunity in special inactive CHB infection.Results: Compared to HBV in HCC, HBV sequencing analysis of 28 LR/RA CHB patients with genotypes B and C showed higher genetic diversity among four ORFs, but the two groups presented similar selective pressure. Seven positive selection sites in the pre-S1 region are potentially associated with immune evasion. These mutations in the pre-S/S region might be associated with the HCC phenotype of low HBsAg expression, with the P region possibly impacting high viral loads.Conclusion: According to the results of this study, LR/RA CHB is characterized by not only genetic diversity but also positive evolutionary pressure within the pre-S/S regions. Increased viral diversity across the HBV genome is also associated with low levels of HBsAg. In conclusion, the cumulative evolutionary changes in the HBV pre-S/S regions that facilitate immune evasion should be monitored individually. Due to the similarity of evolutionary characteristics in HCC, low serological responses and high viremia may be associated with the risk of HCC.

A novel hepatitis B virus mutant coexisting with wild type virus in a carrier with negative HBsAg yet positive HBeAg and anti-HBs.

Epidemiological Characteristics of the Carriers with Coexistence of Hbsag and Anti-Hbs Based on A Community Cohort Study

A new vaccine escape mutant of hepatitis B virus causes occult infection.

Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs.

Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen

Gene Heterogeneity of Hepatitis B Virus Isolates from Patients with Severe Hepatitis B.

Evolutionary analysis of pre S/S mutations in HBeAg-negative chronic hepatitis B with HBsAg <100 IU/ml

Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients

Coexistence of Hepatitis B Surface Antigen (hbsag) and Heterologous Subtype-Specific Antibodies to HBsAg among Patients with Chronic Hepatitis B Virus Infection.

Evolutionary Analysis of Pre-S/S Mutations in HBeAg-Negative Chronic Hepatitis B with HBsAg < 100 IU/ml

Concurrent HBsAg and anti-HBs induced by a preS deletion mutant in a chronic hepatitis B patient

Mutations in Surface and Polymerase Gene of Chronic Hepatitis B Patients with Coexisting Hbsag and Anti-Hbs

Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Coexistence of HBsAg and Anti-HBs.

Mutations in Precore and Core Promoter Region of HBV in Patients with Hepatic Failure.

Analysis of clinical characteristics and S gene sequences in chronic asymptomatic HBV carriers with low-level HBsAg

Decreased expression of HBV surface antigen (HBsAg) with sK122R and sV96A co-mutation is associated with an ineffective antibody response in a chronic hepatitis B patient

Occult Hepatitis B Virus Infection with Positive Hepatitis B E Antigen

Occult Hepatitis B: Immunohistochemistry Staining for HBV Antigens on Liver Biopsies and Sequence Analysis of HBV S Gene.

Study on the serology anomaly pattern of HBsAg and HBsAb positive at the same time of patients with HBV infection

Frequency of Hepatitis B Virus E-Minus Mutants Varies among Patients from Different Areas of China.

[Prevalence of Hepatitis B Virus Core Promoter Mutant Isolated from Asymptomatic Carriers from Areas with Higher and Lower Incidence of Hepatocellular Carcinoma in Guangxi].